Falcon Therapeutics, Inc. — Form D
Falcon Therapeutics, Inc. of CHAPEL HILL, NC, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-21. The offering totals $700K, of which $700K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-06-21
- Form: D
- Accession: 0001709056-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $700K
- Amount sold: $700K
- Investors: 2
- Date of first sale: 2017-06-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-289154
Issuer
- Name: Falcon Therapeutics, Inc.
- CIK: 0001709056
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Incorporated: 2015
- Address: 60110 DAVIE, CHAPEL HILL, NC, 27517
- Phone: 919-360-5321
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Matthew G Ewend | Director | Chapel Hill, NC |
| Karen J Giroux | Director | Chapel Hill, NC |
| Shawn D Hingtgen | Director | Chapel Hill, NC |
| Anna M Seal | Director | Chapel Hill, NC |
| Karen J Giroux | Executive Officer | Chapel Hill, NC |
| Anna M Seal | Executive Officer | Chapel Hill, NC |
More